The Oncology Institute, Inc. (TOI) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for The Oncology Institute, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -54.27x | -0.36x | -1.81x | 790.19x | -59.10x | -44.58x |
| P/B Ratio | -209.23x | 6.46x | 2.64x | 0.98x | 6.20x | 22.72x |
| P/S Ratio | 6.54x | 0.06x | 0.46x | 0.48x | 3.18x | 3.40x |
| Profitability | ||||||
| Gross Margin | 15.2% | 13.7% | 18.4% | 20.6% | 20.1% | 19.7% |
| Operating Margin | -7.2% | -15.3% | -23.8% | -32.5% | -22.6% | -4.4% |
| Net Margin | -12.1% | -16.4% | -25.6% | 0.1% | -5.4% | -7.6% |
| EBITDA Margin | -8.5% | -13.7% | -16.7% | -26.8% | -20.7% | -6.0% |
| Liquidity | ||||||
| Current Ratio | 1.59x | 2.15x | 4.12x | 4.39x | 5.17x | 1.04x |
| Quick Ratio | 1.35x | 1.96x | 3.73x | 4.08x | 4.95x | 0.89x |
| Leverage | ||||||
| Debt/Equity | -6.60x | 34.31x | 2.10x | 0.88x | 0.00x | 0.42x |
YoY = year-over-year change. Source: FMP..